Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

Share:

JAMA Editors' Summary

Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

Miscellaneous


Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the September 14, 2021 issue.